NEOG Stock Forecast 2025-2026
Distance to NEOG Price Targets
NEOG Price Momentum
10 Quality Stocks Worth Considering Now
Researching Neogen (NEOG) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on NEOG and similar high-potential opportunities.
Latest NEOG Stock Price Targets & Analyst Predictions
Based on our analysis of 6 Wall Street analysts, NEOG has a bullish consensus with a median price target of $14.00 (ranging from $13.00 to $15.00). Currently trading at $8.43, the median forecast implies a 66.1% upside. This outlook is supported by 2 Buy, 1 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Subbu Nambi at Guggenheim, projecting a 77.9% upside. Conversely, the most conservative target is provided by David Westenberg at Piper Sandler, suggesting a 54.2% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
NEOG Analyst Ratings
NEOG Price Target Range
Latest NEOG Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for NEOG.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jan 21, 2025 | Piper Sandler | David Westenberg | Neutral | Reiterates | $13.00 |
| Dec 19, 2024 | Guggenheim | Subbu Nambi | Buy | Initiates | $15.00 |
| Aug 6, 2024 | Piper Sandler | David Westenberg | Neutral | Maintains | $17.50 |
| Apr 15, 2024 | Piper Sandler | David Westenberg | Neutral | Maintains | $17.00 |
| Jan 18, 2024 | Piper Sandler | David Westenberg | Neutral | Maintains | $19.00 |
| Oct 16, 2023 | Piper Sandler | David Westenberg | Neutral | Maintains | $17.50 |
| Aug 14, 2023 | Wells Fargo | Timothy Daley | Overweight | Maintains | $28.00 |
| Jun 16, 2023 | Wells Fargo | Timothy Daley | Overweight | Initiates | $22.00 |
| Dec 15, 2022 | Piper Sandler | David Westenberg | Neutral | Maintains | $17.00 |
| Nov 22, 2022 | William Blair | Brandon Vazquez | Outperform | Upgrade | $0.00 |
| Oct 10, 2022 | Piper Sandler | David Westenberg | Neutral | Maintains | $14.00 |
| Aug 30, 2022 | Piper Sandler | David Westenberg | Neutral | Maintains | $20.00 |
| Aug 1, 2022 | Piper Sandler | David Westenberg | Neutral | Maintains | $26.00 |
| Jul 12, 2022 | Piper Sandler | Neutral | Initiates | $0.00 | |
| Mar 19, 2019 | Craig-Hallum | Buy | Upgrade | $0.00 | |
| Mar 27, 2018 | Stephens & Co. | Drew Jones | Equal-Weight | Maintains | $65.00 |
| Jul 14, 2017 | CL King | Neutral | Initiates | $0.00 | |
| Dec 22, 2015 | Craig-Hallum | Hold | Downgrade | $0.00 | |
| Mar 17, 2015 | Stephens & Co. | Equal-Weight | Downgrade | $0.00 | |
| Aug 11, 2014 | Cowen & Co. | Initiates | $0.00 |
Neogen Corporation (NEOG) Competitors
The following stocks are similar to Neogen based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Neogen Corporation (NEOG) Financial Data
Neogen Corporation has a market capitalization of $1.83B with a P/E ratio of 865.0x. The company generates $913.83M in trailing twelve-month revenue with a -52.1% profit margin.
Revenue growth is +0.7% quarter-over-quarter, while maintaining an operating margin of +1.7% and return on equity of -16.4%.
Valuation Metrics
Growth & Margins
Financial Health
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Neogen Corporation (NEOG) Business Model
About Neogen Corporation
Provides food and animal safety solutions.
Neogen Corporation generates revenue by developing and marketing a wide range of products aimed at improving safety in the food and animal industries. Their offerings include diagnostic tests, pharmaceuticals, and hygiene solutions, catering to sectors like agrochemical, veterinary, and food production.
Founded in 1981 and based in Lansing, Michigan, Neogen has established itself as a key player in food safety and animal health. The company's innovative solutions address critical issues such as pathogen detection and livestock productivity, thereby enhancing compliance and safety standards in the global food supply chain.
Company Information
Sector
Healthcare
Industry
Diagnostics & Research
Employees
2,917
CEO
Mr. John Edward Adent
Country
United States
IPO Year
1994
Website
www.neogen.comNeogen Corporation (NEOG) Latest News & Analysis
Neogen Corporation (NASDAQ: NEOG) will release its third-quarter earnings on April 9, 2025, before market opening.
Neogen's upcoming earnings release may impact its stock price, reflecting financial performance and future outlook, influencing investor sentiment and trading decisions.
Neogen Corporation (NASDAQ: NEOG) announced that the National Labor Relations Board has withdrawn its unfair labor practices claim against the company.
The NLRB's withdrawal of the unfair labor practices claim removes a potential legal and financial risk for Neogen, positively impacting its reputation and stock stability.
Vertiv expects 16%-18% revenue growth for 2025, fueled by AI demand. Chart Industries anticipates 12% revenue and 18% EBITDA growth. Intapp reports 17% revenue growth, supported by strong AI demand.
Strong growth projections and increased profit margins for Vertiv, Chart Industries, and Intapp indicate robust demand in AI and data centers, signaling potential investment opportunities.
Neogen® Introduces Igenity® BCHF to Help Industry Mitigate Bovine Congestive Heart Failure Risk
2 months agoNeogen Corporation (NASDAQ: NEOG) has launched Igenity® BCHF, a new product aimed at enhancing bovine heart health standards.
Neogen's launch of Igenity® BCHF enhances its product portfolio in food security, potentially driving revenue growth and market share in the livestock health sector.
Neogen Corporation (NASDAQ: NEOG) has launched the Neogen Molecular Detection Assay 2 – Quantitative Salmonella (MDA2QSAL96), enhancing its food safety solutions.
Neogen's launch of the new detection assay enhances its product portfolio, potentially increasing market share and revenue, which can positively impact stock performance.
Neogen has launched the Molecular Detection Assay 2 - Quantitative Salmonella (MDA2QSAL96), designed for improved consistency and sensitivity in testing, streamlining workflow and resource usage.
Neogen's new assay enhances food safety testing efficiency, potentially boosting market demand and revenue, making it a key development for stakeholders in the food industry.
Frequently Asked Questions About NEOG Stock
What is Neogen Corporation's (NEOG) stock forecast for 2025?
Based on our analysis of 6 Wall Street analysts, Neogen Corporation (NEOG) has a median price target of $14.00. The highest price target is $15.00 and the lowest is $13.00.
Is NEOG stock a good investment in 2025?
According to current analyst ratings, NEOG has 2 Buy ratings, 1 Hold ratings, and 0 Sell ratings. The stock is currently trading at $8.43. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for NEOG stock?
Wall Street analysts predict NEOG stock could reach $14.00 in the next 12 months. This represents a 66.1% increase from the current price of $8.43. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Neogen Corporation's business model?
Neogen Corporation generates revenue by developing and marketing a wide range of products aimed at improving safety in the food and animal industries. Their offerings include diagnostic tests, pharmaceuticals, and hygiene solutions, catering to sectors like agrochemical, veterinary, and food production.
What is the highest forecasted price for NEOG Neogen Corporation?
The highest price target for NEOG is $15.00 from Subbu Nambi at Guggenheim, which represents a 77.9% increase from the current price of $8.43.
What is the lowest forecasted price for NEOG Neogen Corporation?
The lowest price target for NEOG is $13.00 from David Westenberg at Piper Sandler, which represents a 54.2% increase from the current price of $8.43.
What is the overall NEOG consensus from analysts for Neogen Corporation?
The overall analyst consensus for NEOG is bullish. Out of 6 Wall Street analysts, 2 rate it as Buy, 1 as Hold, and 0 as Sell, with a median price target of $14.00.
How accurate are NEOG stock price projections?
Stock price projections, including those for Neogen Corporation, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
